Griesheim, Germany

Anke Zobywalski

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt, Helmholtz Zentrum München Deutsches Forschungszentrym Für Gesundheit Und Umwelt (Gmbh). Active years: 2014-2016.

USPTO Granted Patents = 2 

% Patents Active = 50.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Griesheim, DE (2014)
  • Grieshiem, DE (2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anke Zobywalski: Innovator in Dendritic Cell Research

Introduction

Anke Zobywalski, a notable inventor based in Griesheim, Germany, has made significant contributions to the scientific community with her innovative research focused on dendritic cells. With two patents to her name, Zobywalski has developed methods that enhance the maturation of dendritic cells, which are crucial in immune response.

Latest Patents

Zobywalski's latest patents revolve around compositions for the preparation of mature dendritic cells. The inventions describe a method for the in vitro maturation of immature dendritic cells. This method involves stimulating the cells with TNFα, IL-1β, IFNγ, a TLR7/8 agonist, and Prostaglandin E2 (PG). These patents also detail compositions that contain these factors and the mature dendritic cells produced using the described method.

Career Highlights

Throughout her career, Zobywalski has been associated with reputable research institutions, notably the Helmholtz Zentrum München – Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Her work has been critical in advancing the understanding and application of dendritic cell maturation, aiding in the development of new therapeutic strategies.

Collaborations

Anke Zobywalski has collaborated with esteemed colleagues in her field, including Dolores Schendel and Iris Bigalke. These partnerships have contributed to her research's success and broadened the scope of her innovative work.

Conclusion

Anke Zobywalski exemplifies the impact of dedicated research and innovation in immunology. Her patents represent a significant leap forward in the preparation of mature dendritic cells, opening new avenues for medical applications. As she continues her work, the scientific community eagerly anticipates her future contributions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…